lobbying_activities: 1689568

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1689568	841047b9-c46b-4a4b-8500-dcfa61a3e62c	2T	ANGELA STEWART	401103673	EISAI, INC	2015	second_quarter	PHA	DEA scheduling of controlled substances Improving Regulatory Transparency for New Medical Therapies Act (H.R. 639/S. 481)	HOUSE OF REPRESENTATIVES,SENATE	30000		0	1	2015-06-11T16:00:20.950000-04:00